Priority Date: 05.08.08 (US 20080086355P)

COMPOSITIONS AND METHODS FOR ANTIBODIES AGAINST COMPLEMENT PROTEIN C5

  • Application ID: EP09737379
  • Status: No opposition filed within time limit

Applicant

Technology company logo small
Technology Company

Attorneys

no operation time available
1 office
Technology Company
no operation time available
1 office
Technology Company

Specialization

This EP application has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C07 (ORGANIC CHEMISTRY). Novartis Pharma AG is specialized in the combination A61 and C07. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 221 others are specialized in all of these IPC classes as well. For a similar patent, they might be a good choice.

Timeline

  • 05.08.2008 - Priority Date (US 20080086355P)
  • 11.02.2010 - Publication A1 (WO2010015608)
  • 08.06.2011 - Publication A1 (EP2328616)
  • 29.04.2015 - Publication B1 (EP2328616)

IPC Classification